Table 1 Characteristics of the included studies
From: Meta-analysis on the treatment of diabetic foot ulcers with autologous stem cells
Study | Mean age (years) | Participant cases (treatment group) | Stem cell type | Baseline ulcer size (cm2) | Cell number | Delivery method | Placebo | Follow-up duration (weeks) | Adverse events |
|---|---|---|---|---|---|---|---|---|---|
Lu et al., 2011, China [18] | 65 | 11 | BMMNCs | 4.3 | NA | i.m. | N.S. | 24 | No |
Lu et al., 2011, China [18] | 63 | 11 | BMMSCs | 4.2 | NA | i.m. | N.S. | 24 | No |
Huang et al., 2005, China [19] | 71 | 18 | PBMNCs | 2.7 | 3 × 109/leg | i.m. | PGE1 | 12 | No |
Kirana et al., 2012, Germany [20] | 69 | 12 | BMMNCs | 9.6 | 3 × 108/leg | i.m. | No | 45 | No |
Kirana et al., 2012, Germany [20] | 71 | 12 | BMTRCs | 7.7 | 8 × 107/leg | i.m. | No | 45 | No |
Han et al., 2010, Korea [21] | 67 | 26 | PLA cells | 4.3 | > 4 × 106/ulcer | Ad.us.ext. | No | 8 | No |